BONVIVA 3 mg, solution for injection syringe, 3 ml
Active ingredients: Ibandronic acid, Ibandronate sodium hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 3 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BONVIVA 3 mg, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 3 ml avec 1 aiguille
- Marketing authorisation holder
- ATNAHS PHARMA UK (ROYAUME-UNI)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Oct 2007
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63460631CIP73768718CIP133400937687188Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IBANDRONIQUE (ACIDE)solution | 3 mg · une seringue pré-remplie | FT |
| IBANDRONIQUE (ACIDE), SEL MONOSODIQUE, MONOHYDRATÉsolution | 3,375 mg · une seringue pré-remplie | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.